Use of Transfer Factor as a Novel Immune Therapeutic

National Institute Of Allergy And Infectious Diseases

Investigators

Linked publications & trials

Abstract

We have discovered that TF is not mere assay artifact; we show that TF is derived from antigen-specific CD8+ memory T-cells, acts upon APCs to induce IL-6, and subsequently stimulates memory Tc17 activity to enhance responses in mucosal challenge models for both mice and humans. We found that the molecule responsible for these effects is larger than previously reported. We obtained partial sequencing of TF, with analytical chemistry evidence suggesting a hybrid molecule of S100 peptides and the beta chain of the TCR. We are now setting up mass spec analysis to clone the molecule and assess its presence in human breast milk. In FY25 we continued to work towards identification and cloning of the molecule.